You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Population pharmacokinetics of imatinib mesylate in nigerian patients with chronic myeloid leukemia
- In: SUBMITTED ORALS on Wednesday, 16 April 2014, 14:30-15:30
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: ADEAGBO, Babatunde (Obafemi Awolowo University, Department of Pharmaceutical Chemistry, Ile-ife, Nigeria)
- Co-author(s): Bolaji, Oluseye (Obafemi Awolowo University, Ile-ife, Nigeria)
Olugbade, Tiwalade (Obafemi Awolowo University, Ile-ife, Nigeria)
Durosinmi, Muheez (Obafemi Awolowo University, Ile-ife, Nigeria)
Bolarinwa, Rahaman (Obafemi Awolowo University, Ile-ife, Nigeria)
Ogungbenro, Kayode (University of Manchester, Manchester, United Kingdom) - Abstract:
Background: Population pharmacokinetic studies of imatinib mesylate in Caucasian and Japanese patients with chronic myeloid leukaemia (CML) have shown inter-subject and inter-population clearance variabilities. However, no pharmacokinetic (PK) study has been conducted in an African population since the introduction of the drug.
Aim: This study.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026